Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus Coagulans SBC37-01, MTCC 5856

摘要

#$%^&*AU2016358297A120170727.pdf#####ABSTRACT The present invention discloses a process for the therapeutic management of diarrhea predominant irritable bowel syndrome in humans comprising the oral administration of Bacillus coagulans SBC37-01, MTCC 5856 (containing not less than 2 billion spores) along with standard treatment of care in a specific manner. Page 1 of 1